Open to Innovative Products and Partnerships

Upsher-Smith is proud of its heritage as a trusted name in pharmaceuticals. As we enter our 100th year in business, we embark on a new ambitious era energized by our collaboration with Sawai Pharmaceutical Co., Ltd. and Sumitomo Corp. of Americas.

Focused on providing cost-effective therapies for U.S. patients, we seek to expand our network of global partners so that we can deliver high-quality, health-improving products across increasingly diverse dosage forms.

Upsher-Smith has a particular interest in partners who have a solid history of success, as well as a vision for future growth and innovation. We are driven to positively impact patients’ lives; with partners who share this drive, we are confident we can achieve growth, and most importantly, do more good for the patients we serve.

As a prospective business partner, Upsher-Smith offers the following advantages:

A customer-centric reputation. We’re tirelessly committed to consistent product supply, fast and accurate deliveries, intimate account knowledge, and customer service. We invest in strong relationships with our business partners throughout the supply chain.

A highly adaptive approach. Throughout our history, we’ve collaborated with a variety of U.S. and international partners, from established, high-revenue, multinational corporations to niche, privately-held, regional firms. We approach our collaborations one at a time and are open to creative and unique arrangements. Ultimately, we seek to align our interests with those of our partners, so that, together, we can address both the known challenges of today and the unexpected challenges of the future.

Local focus with global scale. Upsher-Smith remains primarily focused on U.S. commercial growth in the generics and brand businesses, yet with our growing base of partners and shareholders, we have access to global-scale capabilities, knowledge and expertise.

For more information, please contact our Corporate Development team at